Medication Management of Cardiac Allograft Vasculopathy After Heart Transplantation

Publisher： John Wiley & Sons Inc

E-ISSN： 1875-9114|35|5|489-501

ISSN： 0277-0008

Source： PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol.35, Iss.5, 2015-05, pp. : 489-501

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The predictive value of coronary artery calcium detected by computed tomography in a prospective study on cardiac allograft vasculopathy in heart transplant patients

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 31, Iss. 1, 2018-01 ,pp. : 82-91

John Wiley & Sons Inc

Access to resources Recommend Favorite

C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 7, 2015-07 ,pp. : 857-863

John Wiley & Sons Inc

Access to resources Recommend Favorite

Coronary Microvascular Dysfunction Correlates With the New Onset of Cardiac Allograft Vasculopathy in Heart Transplant Patients With Normal Coronary Angiography

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 5, 2015-05 ,pp. : 1400-1406

John Wiley & Sons Inc

Access to resources Recommend Favorite

Angioplasty versus stenting for cardiac allograft vasculopathy

By Dieter Robert S   Gauthier Greg M   Nanjundappa Aravinda   Wolff Matthew R  

Therapy, Vol. 3, Iss. 4, 2006-07 ,pp. : 517-520

Future Medicine

Access to resources Recommend Favorite

Virtual Histology and the Morphologic Assessment of Cardiac Allograft Vasculopathy

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 13, Iss. 4, 2013-04 ,pp. : 1109-1109

John Wiley & Sons Inc

Access to resources Recommend Favorite